The Asia Pacific Electroencephalography Devices Market would witness market growth of 10.3% CAGR during the forecast period (2022-2028).
Alzheimer’s disease (AD) is a form of dementia that is growing relatively fast among the aging population. It accounts for more than half of all dementia-associated diseases. AD generally begins in the brain in parts where healthy neurons have stopped working efficiently and collapsed. From there, the disorder progresses to other parts which then begin to reduce.
Simultaneously, the neurofibrillary tangles and beta-amyloid plaques spread throughout the brain. These essentially hinder the transmission of information between the remaining neurons. Some other common brain disorders include Parkinson’s disease (increased tremors lead to difficulty in movement, walking, and coordination) and strokes (disrupted blood flow because of the blocked blood vessel in the brain).
Apart from brain disorders, reduced cognitive health also causes mental disorders or psychiatric disorders. These are illnesses or conditions that disrupt individuals’ thinking, mood, daily functioning, feeling, and capability to relate to others. The disorders that are known as mental disorders primarily include anxiety disorders, depression, schizophrenia, addiction disorders, personality disorders, and many more. EEG devices are also used in the diagnosis of primary brain tumors.
In this region, south Asian nations have reported a high incidence of some common mental disorders (CMDs). These nations contain almost a quarter of the global population and a significant proportion of their population is well above 65 years of age. Approximately, 150 to 200 million people in the region have a diagnosed mental disorder and restrained access to healthcare. The region also witnesses a significant lack of psychiatrists as well as clinical psychologists, social workers, and other mental health practitioners.
The China market dominated the Asia Pacific Electroencephalography Devices Market by Country in 2021; thereby, achieving a market value of $136.2 million by 2028. The Japan market is registering a CAGR of 9.6% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 11% during (2022 - 2028).
Based on Type, the market is segmented into Standalone and Portable. Based on End User, the market is segmented into Hospitals, Diagnostic Centers and Others. Based on Product, the market is segmented into 32-channel, 25-channel, 40-channel, 21-channel, 8-channel and Multichannel. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Electroencephalography Devices Market is Projected to reach USD 1.8 Billion by 2028, at a CAGR of 9.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Compumedics Limited, Natus Medical Incorporated (Archimed SAS), Nihon Kohden Corporation, Cadwell Industries, Inc., Neurowave Systems, Inc., Magstim EGI (Magstim, Inc.) and Noraxon U.S.A., Inc.
By Type
By End User
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 